News Headlines Article

Bay Area obesity drug maker slims down as market slows
San Francisco Business Times

Facing a slower market for fat-fighting drugs and needing cash for an important safety study, Vivus Inc. said it will cut staff at its Mountain View headquarters and among its sales force. The restructure move is immediate, Vivus (NASDAQ: VVUS) CEO Seth Fischer said in a press release Thursday, and is aimed at hitting neutral or positive operating cash flows by year-end 2016.